Serum complement and familial combined hyperlipidemia (Q50961761)

26 March 2018

title

Serum complement and familial combined hyperlipidemia (English)

1 reference

26 March 2018

1 reference

Marja-Riitta Taskinen

11

object named as

M R Taskinen

1 reference

26 March 2018

author name string

K Ylitalo

1

1 reference

26 March 2018

K V Porkka

2

1 reference

26 March 2018

S Meri

3

1 reference

26 March 2018

I Nuotio

4

1 reference

26 March 2018

L Suurinkeroinen

5

1 reference

26 March 2018

J Vakkilainen

6

1 reference

26 March 2018

P Pajukanta

7

1 reference

26 March 2018

J S Viikari

8

1 reference

26 March 2018

L Peltonen

9

1 reference

26 March 2018

C Ehnholm

10

1 reference

26 March 2018

publication date

1 March 1997

1 reference

26 March 2018

published in

Atherosclerosis

1 reference

26 March 2018

volume

129

1 reference

26 March 2018

issue

2

1 reference

26 March 2018

page(s)

271-277

1 reference

26 March 2018

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Family study of serum lipids and lipoproteins in coronary heart-disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Familial lipoprotein disorders in patients with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Activation of the human terminal complement pathway in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Association of serum IgA and C4 with severe atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Correlations between serum lipids and complement components in adults without demonstrated atherosclerotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Analysis of serial measurements in medical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Association of serum C3 levels with the risk of myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Molecular cloning and characterization of the human anaphylatoxin C3a receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906054-6

10.1016/S0021-9150(96)06054-6

7 January 2021

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018